Biocytogen Pharmaceuticals (Beijing) Co (FRA:I54) Sale Of Property, Plant, Equipment : €0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Biocytogen Pharmaceuticals (Beijing) Co Sale Of Property, Plant, Equipment?

Biocytogen Pharmaceuticals (Beijing) Co's sale of property, plant, equipment for the six months ended in Dec. 2024 was €0.0 Mil. It means Biocytogen Pharmaceuticals (Beijing) Co gained €0.0 Mil from selling property, plant, and equipment. Biocytogen Pharmaceuticals (Beijing) Co's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Jun. 2024 ), Biocytogen Pharmaceuticals (Beijing) Co gained less money from selling property, plant, and equipment in Dec. 2024 (€0.0 Mil).

Biocytogen Pharmaceuticals (Beijing) Co Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Biocytogen Pharmaceuticals (Beijing) Co's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocytogen Pharmaceuticals (Beijing) Co Sale Of Property, Plant, Equipment Chart

Biocytogen Pharmaceuticals (Beijing) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Sale Of Property, Plant, Equipment

0.01

0.66

0.22

3.38

Biocytogen Pharmaceuticals (Beijing) Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Sale Of Property, Plant, Equipment	Get a 7-Day Free Trial				0.21	0.03	3.35	0.04	-

Biocytogen Pharmaceuticals (Beijing) Co Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

Biocytogen Pharmaceuticals (Beijing) Co Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Biocytogen Pharmaceuticals (Beijing) Co's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocytogen Pharmaceuticals (Beijing) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocytogen Pharmaceuticals (Beijing) Co Ltd (FRA:I54) » Definitions » Sale Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

02315:Hong Kong

Address

12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District, Beijing, CHN

Website

https://www.biocytogen.com.cn

Biocytogen Pharmaceuticals (Beijing) Co Ltd is a biopharmaceutical and pre-clinical research services company. It has two Core Products, YH003 and YH001. YH003 is a recombinant humanized agonistic anti-Cluster of Differentiation 40 (CD40) Immunoglobulin G2 (IgG2) monoclonal antibody and YH001 is a recombinant humanized anti-CTLA-4, a protein receptor expressed constitutively on T cells that functions as an immune checkpoint and downregulates immune responses, Immunoglobulin G1 (IgG1) monoclonal antibody. YH003 is being developed for pancreatic ductal adenocarcinoma, melanoma, and other advanced solid tumors. YH001 is being developed for hepatocellular carcinoma (HCC), non-small-cell lung carcinoma (NSCLC), and other solid tumors.

Biocytogen Pharmaceuticals (Beijing) Co Headlines

No Headlines